NL190662C - alfa-Halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat dat dit bevat. - Google Patents
alfa-Halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat dat dit bevat.Info
- Publication number
- NL190662C NL190662C NL7807453A NL7807453A NL190662C NL 190662 C NL190662 C NL 190662C NL 7807453 A NL7807453 A NL 7807453A NL 7807453 A NL7807453 A NL 7807453A NL 190662 C NL190662 C NL 190662C
- Authority
- NL
- Netherlands
- Prior art keywords
- alpha
- halo
- methyl
- amino acid
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81476577A | 1977-07-11 | 1977-07-11 | |
US2875779A | 1979-04-10 | 1979-04-10 | |
US2875879A | 1979-04-10 | 1979-04-10 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7807453A NL7807453A (nl) | 1979-01-15 |
NL190662B NL190662B (nl) | 1994-01-17 |
NL190662C true NL190662C (nl) | 1994-06-16 |
Family
ID=27363337
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7807453A NL190662C (nl) | 1977-07-11 | 1978-07-11 | alfa-Halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat dat dit bevat. |
NL950027C NL950027I2 (nl) | 1977-07-11 | 1995-11-17 | Alfa-halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat die dit bevat. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL950027C NL950027I2 (nl) | 1977-07-11 | 1995-11-17 | Alfa-halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat die dit bevat. |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5419913A (fi) |
AU (1) | AU522660B2 (fi) |
BE (3) | BE868882A (fi) |
CA (1) | CA1091661A (fi) |
CH (1) | CH642055A5 (fi) |
DE (1) | DE2828739A1 (fi) |
FR (1) | FR2430418A1 (fi) |
GB (1) | GB2001960B (fi) |
NL (2) | NL190662C (fi) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399151A (en) | 1980-06-16 | 1983-08-16 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting the growth of protozoa |
SE460517B (sv) * | 1980-06-16 | 1989-10-23 | Merrell Pharma Inc | Anvaendning av en foerening foer framstaellning av ett laekemedel foer behandling av infektioner orsakade av trypanosoma brucei |
GB2083030B (en) * | 1980-08-23 | 1984-03-07 | Merrell Toraude & Co | Fluorinated pentene diamine derivatives |
ZA815808B (en) * | 1980-08-23 | 1982-08-25 | Merrell Toraude & Co | Fluorinated pentene diamine derivatives |
US4437873A (en) | 1981-03-23 | 1984-03-20 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting algae |
US4446151A (en) * | 1981-08-19 | 1984-05-01 | Merrell Toraude Et Compagnie | Decarboxylase-inhibiting fluorinated pentane diamine derivatives |
US4423073A (en) | 1981-08-19 | 1983-12-27 | Merrell Toraude Et Compagnie | Fluorinated diaminopentene derivatives |
US4435425A (en) | 1982-04-09 | 1984-03-06 | Merrell Toraude Et Compagnie | Fluorinated diaminobutane derivatives |
JPS62148462A (ja) * | 1985-12-19 | 1987-07-02 | メレルダウフア−マス−テイカルズ インコ−ポレ−テツド | 原生動物の生長を抑制する新規な方法 |
EP0326766B1 (en) * | 1988-02-05 | 1992-06-17 | Merrell Dow Pharmaceuticals Inc. | 5-substituted ornithine derivatives |
CA1319123C (en) * | 1988-08-31 | 1993-06-15 | Andrew T. Au | Method for the production of (-) 2-substituted-ornithines |
US6103220A (en) * | 1998-01-23 | 2000-08-15 | Levine; Martin | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
US6187296B1 (en) | 1998-01-23 | 2001-02-13 | The Board Of Regents Of The University Of Oklahoma | Lysine decarboxylase inhibitors for the prevention and treatment of periodontal disease |
US7015349B2 (en) | 2003-03-26 | 2006-03-21 | The Gillette Company | Reduction of hair growth |
WO2021209563A1 (en) | 2020-04-16 | 2021-10-21 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ187377A (en) * | 1977-06-01 | 1981-05-15 | Merck & Co Inc | A-amino-a-substituted alkyl-a-fluoromethylacetic acids |
-
1978
- 1978-06-07 CA CA304,918A patent/CA1091661A/en not_active Expired
- 1978-06-21 AU AU37327/78A patent/AU522660B2/en not_active Expired
- 1978-06-27 GB GB7827967A patent/GB2001960B/en not_active Expired
- 1978-06-30 DE DE19782828739 patent/DE2828739A1/de active Granted
- 1978-07-10 BE BE189191A patent/BE868882A/xx not_active IP Right Cessation
- 1978-07-10 FR FR7820517A patent/FR2430418A1/fr active Granted
- 1978-07-10 CH CH746678A patent/CH642055A5/de not_active IP Right Cessation
- 1978-07-11 JP JP8361978A patent/JPS5419913A/ja active Granted
- 1978-07-11 NL NL7807453A patent/NL190662C/xx not_active IP Right Cessation
-
1980
- 1980-01-17 BE BE0/199012A patent/BE881209A/fr not_active IP Right Cessation
- 1980-01-17 BE BE0/199011A patent/BE881208A/fr not_active IP Right Cessation
-
1995
- 1995-11-17 NL NL950027C patent/NL950027I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
DE2828739A1 (de) | 1979-02-01 |
CH642055A5 (de) | 1984-03-30 |
FR2430418A1 (fr) | 1980-02-01 |
AU522660B2 (en) | 1982-06-17 |
BE881209A (fr) | 1980-05-16 |
CA1091661A (en) | 1980-12-16 |
GB2001960A (en) | 1979-02-14 |
BE868882A (fr) | 1978-11-03 |
FR2430418B1 (fi) | 1984-07-13 |
JPS5419913A (en) | 1979-02-15 |
JPH0122259B2 (fi) | 1989-04-25 |
NL950027I1 (nl) | 1996-02-01 |
NL190662B (nl) | 1994-01-17 |
NL7807453A (nl) | 1979-01-15 |
BE881208A (fr) | 1980-05-16 |
AU3732778A (en) | 1980-01-03 |
NL950027I2 (nl) | 1997-06-02 |
GB2001960B (en) | 1982-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK541878A (da) | Phthalazin-4-yleddikesyrederivater | |
NL190519B (nl) | 4-gesubstitueerde fenylazijnzuurverbindingen, alsmede farmaceutische preparaten. | |
DK136579A (da) | Thioetiansyrederivater | |
BE872319A (fr) | Composition pharmaceutique | |
NL7606655A (nl) | Imidylbenzeendi- en -tricarbonzuurderivaten. | |
PL197552A1 (pl) | Srodek chwastobojczy zawierajacy pochodne kwasu fenoksy-fenoksy-propionowego | |
SE7811637L (sv) | Cefalosporansyraderivat, forfaranden for framstellning derav och farmaceutisk komposition innehallande desamma | |
SE7711395L (sv) | Farmaceutisk komposition | |
NL190662C (nl) | alfa-Halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat dat dit bevat. | |
SE7809373L (sv) | Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat | |
NL188645C (nl) | 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten. | |
IT1095377B (it) | Composizione farmaceutica | |
NO147437C (no) | Partikkelformig forstoff for droevtyggere. | |
FI790404A (fi) | Farmaceutiska sammansaettningar | |
DK501880A (da) | Cyclopropancarboxylsyreesterderivater | |
SE7806441L (sv) | Lekemedelskomposition | |
NL7801921A (nl) | Farmaceutische preparaten. | |
AU526259B2 (en) | Pseudomonic acid c and derivatives thereof | |
NL7807871A (nl) | Alpha-halogeenmethylaminozuur derivaten. | |
SE7705658L (sv) | Farmaceutisk komposition | |
NL7801576A (nl) | Benzoheterocyclylglyoxylzuurderivaten. | |
FI783049A (fi) | Farmaceutiskt aktiva(omega-aminoalkoxi)dibenzyler | |
DK209880A (da) | Benzofurancarboxylsyrederivater | |
FI781507A (fi) | Farmaceutiska kompositioner | |
NL184896C (nl) | Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
U | Licences registered with regard to patents granted | ||
AC1 | Application for a supplementary protection certificate |
Free format text: 0950027, 951117 |
|
TNT | Modifications of names of proprietors of patents or applicants of examined patent applications |
Owner name: MARION MERRELL ET COMPAGNIE;MARION MERRELL DOW ET |
|
KC1 | Grant of a supplementary protection certificate |
Free format text: 950027, 19980711, EXPIRES: 20030710 |
|
V4 | Lapsed because of reaching the maximum lifetime of a patent |
Free format text: 980711 |